Gilead’s Coronavirus Drug Trial Slowed Due to Lack of Eligible Recruits

A trial of Gilead’s coronavirus drug has been slowed, as eligible recruits prove hard to come by

The trials, aimed at testing more than 700 patients infected with the Wuhan coronavirus, have succeeded in recruiting fewer than 200 people after 10 days.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New Zealand PM Ardern sees 2020 growth slowing to 2-2.5% due to coronavirusNew Zealand Prime Minister Jacinda Ardern said on Monday that the country's...
Read more »

Japan to start trials using HIV treatment for coronavirus: SugaJapan is aiming to start trials soon using an HIV treatment for the coronavirus,...
Read more »

Japan to start trials using HIV treatment for coronavirus - SugaJapan is aiming to start trials soon using an HIV treatment for the coronavirus,...
Read more »

Japan plans HIV drug trials for coronavirus, cruise ship evacuations continueJapan plans HIV drug trials for coronavirus, cruise ship evacuations continue by sakmurakami juminism For the latest developments around the new coronavirus outbreak, follow our liveblog:
Read more »

Coronavirus infections slow in China as Apple warns of iPhone shortagesThe number of new coronavirus infections in mainland China fell below 2,000 on T...
Read more »

Global goods trade already slow; coronavirus will likely make it worse, WTO saysGlobal trade in goods will likely be weak in coming months as disruptions from the coronavirus outbreak stanch the movement of international commerce.
Read more »